Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders

Frontiers in Genetics

Volumn 6, Issue JUN, 2015, Pages

  Usdin, Karen ^a   Kumari, Daman ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Fragile X syndrome; Fragile X associated primary ovarian insufficiency; Fragile X associated tremor ataxia syndrome; Polycomb repressive complex 2; R loops; Repeat mediated gene silencing

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; REPETITIVE DNA;

ALLELE; EPIGENETICS; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; HETEROZYGOTE; HUMAN; NONHUMAN; PREMATURE OVARIAN FAILURE; REVIEW;

EID: 84940100820     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00192     Document Type: Review

References (91)

1. Avitzour, M., Mor-Shaked, H., Yanovsky-Dagan, S., Aharoni, S., Altarescu, G., Renbaum, P., et al. (2014). FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells. Stem Cell Reports 3, 699-706. doi: 10.1016/j.stemcr.2014.09.001.
2. Beilina, A., Tassone, F., Schwartz, P. H., Sahota, P., and Hagerman, P. J. (2004). Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum. Mol. Genet. 13, 543-549. doi: 10.1093/hmg/ddh053.
3. Belzil, V. V., Bauer, P. O., Prudencio, M., Gendron, T. F., Stetler, C. T., Yan, I. K., et al. (2013). Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neupathol. 126, 895-905. doi: 10.1007/s00401-013-1199-1.
4. Biacsi, R., Kumari, D., and Usdin, K. (2008). SIRT1 inhibition alleviates gene silencing in fragile X mental retardation syndrome. PLoS Genet. 4:e1000017. doi: 10.1371/journal.pgen.1000017.
5. Bierhoff, H., Dammert, M. A., Brocks, D., Dambacher, S., Schotta, G., and Grummt, I. (2014). Quiescence-induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing. Mol. Cell 54, 675-682. doi: 10.1016/j.molcel.2014.03.032.
6. Blackledge, N. P., Thomson, J. P., and Skene, P. J. (2013). CpG island chromatin is shaped by recruitment of ZF-CxxC proteins. Cold Spring Harb. Perspect. Biol. 5, a018648. doi: 10.1101/cshperspect.a018648.
7. Brouwer, J. R., Huizer, K., Severijnen, L. A., Hukema, R. K., Berman, R. F., Oostra, B. A., et al. (2008). CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J. Neurochem. 107, 1671-1682. doi: 10.1111/j.1471-4159.2008.05747.x.
8. Castellano-Pozo, M., Santos-Pereira, J. M., Rondon, A. G., Barroso, S., Andujar, E., Perez-Alegre, M., et al. (2013). R loops are linked to histone H3 S10 phosphorylation and chromatin condensation. Mol. Cell 52, 583-590. doi: 10.1016/j.molcel.2013.10.006.
9. Chaudhuri, J., Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F. W. (2003). Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730. doi: 10.1038/nature01574.
10. Chiurazzi, P., Pomponi, M. G., Pietrobono, R., Bakker, C. E., Neri, G., and Oostra, B. A. (1999). Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene. Hum. Mol. Genet. 8, 2317-2323. doi: 10.1093/hmg/8.12.2317.
11. Chiurazzi, P., Pomponi, M. G., Willemsen, R., Oostra, B. A., and Neri, G. (1998). In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum. Mol. Genet. 7, 109-113. doi: 10.1093/hmg/7.1.109.
12. Cho, D. H., Thienes, C. P., Mahoney, S. E., Analau, E., Filippova, G. N., and Tapscott, S. J. (2005). Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20, 483-489. doi: 10.1016/j.molcel.2005.09.002.
13. Cifuentes-Rojas, C., Hernandez, A. J., Sarma, K., and Lee, J. T. (2014). Regulatory interactions between RNA and polycomb repressive complex 2. Mol. Cell 55, 171-185. doi: 10.1016/j.molcel.2014.05.009.
14. Clouaire, T., Webb, S., Skene, P., Illingworth, R., Kerr, A., Andrews, R., et al. (2012). Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev. 26, 1714-1728. doi: 10.1101/gad.194209.112.
15. Coffee, B., Zhang, F., Warren, S. T., and Reines, D. (1999). Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 22, 98-101.
16. Colak, D., Zaninovic, N., Cohen, M. S., Rosenwaks, Z., Yang, W. Y., Gerhardt, J., et al. (2014). Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 343, 1002-1005. doi: 10.1126/science.1245831.
17. Dunn, K., and Griffith, J. D. (1980). The presence of RNA in a double helix inhibits its interaction with histone proteins. Nucl. Acids Res. 11, 555-566.
18. Entezam, A., Biacsi, R., Orrison, B., Saha, T., Hoffman, G. E., Grabczyk, E., et al. (2007). Regional FMRP deficits and large repeat expansions into the full mutation range in a new fragile X premutation mouse model. Gene 395, 125-134. doi: 10.1016/j.gene.2007.02.026.
19. Fratta, P., Mizielinska, S., Nicoll, A. J., Zloh, M., Fisher, E. M., Parkinson, G., et al. (2012). C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2, 1016. doi: 10.1038/srep01016.
20. Fry, M., and Loeb, L. A. (1994). The fragile X syndrome d(CGG)n nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. U.S.A. 91, 4950-4954.
21. Fu, Y. H., Kuhl, D. P., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., et al. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-1058.
22. Gagnon, K. T., Li, L., Chu, Y., Janowski, B. A., and Corey, D. R. (2014). RNAi factors are present and active in human cell nuclei. Cell Rep. 6, 211-221. doi: 10.1016/j.celrep.2013.12.013.
23. Ginno, P. A., Lott, P. L., Christensen, H. C., Korf, I., and Chedin, F. (2012). R-loop formation is a distinctive characteristic of unmethylated human CpG island promoters. Mol. Cell 45, 814-825. doi: 10.1016/j.molcel.2012.01.017.
24. Greene, E., Mahishi, L., Entezam, A., Kumari, D., and Usdin, K. (2007). Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 35, 3383-3390. doi: 10.1093/nar/gkm271.
25. Groh, M., Lufino, M. M., Wade-Martins, R., and Gromak, N. (2014). R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. PLoS Genet. 10:e1004318. doi: 10.1371/journal.pgen.1004318.
26. Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A., Shaw, P. G., Kim, M. S., et al. (2014). C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507, 195-200. doi: 10.1038/nature13124.
27. Hagerman, P. (2013). Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms. Acta Neuropathol. 126, 1-19. doi: 10.1007/s00401-013-1138-1.
28. Handa, V., Saha, T., and Usdin, K. (2003). The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by Dicer. Nucleic Acids Res. 31, 6243-6248. doi: 10.1093/nar/gkg818.
29. Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., and Gottesfeld, J. M. (2006). Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2, 551-558. doi: 10.1038/nchembio815.
30. Jeon, Y., and Lee, J. T. (2011). YY1 tethers Xist RNA to the inactive X nucleation center. Cell 146, 119-133. doi: 10.1016/j.cell.2011.06.026.
31. Kettani, A., Kumar, R. A., and Patel, D. J. (1995). Solution structure of a DNA quadruplex containing the fragile X syndrome triplet repeat. J. Mol. Biol. 254, 638-656.
32. Krajewski, W. A., Nakamura, T., Mazo, A., and Canaani, E. (2005). A motif within SET-domain proteins binds single-stranded nucleic acids and transcribed and supercoiled DNAs and can interfere with assembly of nucleosomes. Mol. Cell. Biol. 25, 1891-1899. doi: 10.1128/MCB.25.5.1891-1899.2005.
33. Kumari, D., and Usdin, K. (2010). The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum. Mol. Genet. 19, 4634-4642. doi: 10.1093/hmg/ddq394.
34. Kumari, D., and Usdin, K. (2014). Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription. Hum. Mol. Genet. 23, 6575-6583. doi: 10.1093/hmg/ddu378.
35. Ladd, P. D., Smith, L. E., Rabaia, N. A., Moore, J. M., Georges, S. A., Hansen, R. S., et al. (2007). An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16, 3174-3187. doi: 10.1093/hmg/ddm293.
36. Levy, M. A., Kernohan, K. D., Jiang, Y., and Berube, N. G. (2015). ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions. Hum. Mol. Genet. 24, 1824-1835. doi: 10.1093/hmg/ddu596.
37. Libri, V., Yandim, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., et al. (2014). Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study. Lancet 384, 504-513. doi: 10.1016/S0140-6736(14)60382-2.
38. Lin, Y., Dent, S. Y., Wilson, J. H., Wells, R. D., and Napierala, M. (2010). R loops stimulate genetic instability of CTG.CAG repeats. Proc. Natl. Acad. Sci. U.S.A. 107, 692-697. doi: 10.1073/pnas.0909740107.
39. Liu, G., Chen, X., Bissler, J. J., Sinden, R. R., and Leffak, M. (2010). Replication-dependent instability at (CTG) x (CAG) repeat hairpins in human cells. Nat. Chem. Biol. 6, 652-659. doi: 10.1038/nchembio.416.
40. Loesch, D. Z., Sherwell, S., Kinsella, G., Tassone, F., Taylor, A., Amor, D., et al. (2012). Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin. Genet. 82, 88-92. doi: 10.1111/j.1399-0004.2011.01675.x.
41. Loomis, E. W., Sanz, L. A., Chedin, F., and Hagerman, P. J. (2014). Transcription-associated R-loop formation across the human FMR1 CGG-repeat region. PLoS Genet. 10:e1004294. doi: 10.1371/journal.pgen.1004294.
42. Malgowska, M., Gudanis, D., Kierzek, R., Wyszko, E., Gabelica, V., and Gdaniec, Z. (2014). Distinctive structural motifs of RNA G-quadruplexes composed of AGG, CGG and UGG trinucleotide repeats. Nucleic Acids Res. 42, 10196-10207. doi: 10.1093/nar/gku710.
43. Mirkin, S. M. (2007). Expandable DNA repeats and human disease. Nature 447, 932-940. doi: 10.1038/nature05977.
44. Mitas, M., Yu, A., Dill, J., and Haworth, I. S. (1995). The trinucleotide repeat sequence d(CGG)15 forms a heat-stable hairpin containing Gsyn. Ganti base pairs. Biochemistry 34, 12803-12811.
45. O'Hagan, H. M., Mohammad, H. P., and Baylin, S. B. (2008). Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island. PLoS Genet. 4:e1000155. doi: 10.1371/journal.pgen.1000155.
46. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., et al. (1991). Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252, 1097-1102. doi: 10.1126/science.252.5009.1097.
47. Ooi, S. K., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., et al. (2007). DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448, 714-717. doi: 10.1038/nature05987.
48. Otten, A. D., and Tapscott, S. J. (1995). Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc. Natl. Acad. Sci. U.S.A. 92, 5465-5469.
49. Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, J., et al. (2008). Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol. Cell 32, 232-246. doi: 10.1016/j.molcel.2008.08.022.
50. Patel, P. K., Bhavesh, N. S., and Hosur, R. V. (2000). Cation-dependent conformational switches in d-TGGCGGC containing two triplet repeats of Fragile X Syndrome: NMR observations. Biochem. Biophys. Res. Commun. 278, 833-838. doi: 10.1006/bbrc.2000.3878.
51. Pieretti, M., Zhang, F. P., Fu, Y. H., Warren, S. T., Oostra, B. A., Caskey, C. T., et al. (1991). Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817-822.
52. Pietrobono, R., Pomponi, M. G., Tabolacci, E., Oostra, B., Chiurazzi, P., and Neri, G. (2002). Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res. 30, 3278-3285. doi: 10.1093/nar/gkf434.
53. Pietrobono, R., Tabolacci, E., Zalfa, F., Zito, I., Terracciano, A., Moscato, U., et al. (2005). Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum. Mol. Genet. 14, 267-277. doi: 10.1093/hmg/ddi024.
54. Popp, C., Dean, W., Feng, S., Cokus, S. J., Andrews, S., Pellegrini, M., et al. (2010). Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463, 1101-1105. doi: 10.1038/nature08829.
55. Powell, W. T., Coulson, R. L., Gonzales, M. L., Crary, F. K., Wong, S. S., Adams, S., et al. (2013). R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl. Acad. Sci. U.S.A. 110, 13938-13943. doi: 10.1073/pnas.1305426110.
56. Reddy, K., Zamiri, B., Stanley, S. Y., Macgregor, R. B. Jr., and Pearson, C. E. (2013). The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni-and multimolecular RNA G-quadruplex structures. J. Biol. Chem. 288, 9860-9866. doi: 10.1074/jbc.C113.452532.
57. Rinn, J. L., and Chang, H. Y. (2012). Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145-166. doi: 10.1146/annurev-biochem-051410-092902.
58. Saha, T., and Usdin, K. (2001). Tetraplex formation by the progressive myoclonus epilepsy type-1 repeat: implications for instability in the repeat expansion diseases. FEBS Lett. 491, 184-187. doi: 10.1016/S0014-5793(01)02190-1.
59. Sareen, D., O'rourke, J. G., Meera, P., Muhammad, A. K., Grant, S., Simpkinson, M., et al. (2013). Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 5, 208ra149. doi: 10.1126/scitranslmed.3007529.
60. Schmitges, F. W., Prusty, A. B., Faty, M., Stutzer, A., Lingaraju, G. M., Aiwazian, J., et al. (2011). Histone methylation by PRC2 is inhibited by active chromatin marks. Mol. Cell. 42, 330-341. doi: 10.1016/j.molcel.2011.03.025.
61. Schmitz, K. M., Mayer, C., Postepska, A., and Grummt, I. (2010). Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 24, 2264-2269. doi: 10.1101/gad.590910.
62. Sellier, C., Usdin, K., Pastori, C., Peschansky, V. J., Tassone, F., and Charlet-Berguerand, N. (2014). The multiple molecular facets of fragile X-associated tremor/ataxia syndrome. J. Neurodev. Disord. 6, 23. doi: 10.1186/1866-1955-6-23.
63. Sherman, S. L., Curnow, E. C., Easley, C. A., Jin, P., Hukema, R. K., Tejada, M. I., et al. (2014). Use of model systems to understand the etiology of fragile X-associated primary ovarian insufficiency (FXPOI). J. Neurodev. Disord. 6, 26. doi: 10.1186/1866-1955-6-26.
64. Skourti-Stathaki, K., Kamieniarz-Gdula, K., and Proudfoot, N. J. (2014). R-loops induce repressive chromatin marks over mammalian gene terminators. Nature 516, 436-439. doi: 10.1038/nature13787.
65. Skourti-Stathaki, K., Proudfoot, N. J., and Gromak, N. (2011). Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol. Cell 42, 794-805. doi: 10.1016/j.molcel.2011.04.026.
66. Smith, S. S., Laayoun, A., Lingeman, R. G., Baker, D. J., and Riley, J. (1994). Hypermethylation of telomere-like foldbacks at codon 12 of the human c-Ha-ras gene and the trinucleotide repeat of the FMR-1 gene of fragile X. J. Mol. Biol. 243, 143-151. doi: 10.1006/jmbi.1994.1640.
67. Sordet, O., Nakamura, A. J., Redon, C. E., and Pommier, Y. (2010). DNA double-strand breaks and ATM activation by transcription-blocking DNA lesions. Cell Cycle 9, 274-278. doi: 10.4161/cc.9.2.10506.
68. Steinbach, P., Glaser, D., Vogel, W., Wolf, M., and Schwemmle, S. (1998). The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am. J. Hum. Genet. 62, 278-285. doi: 10.1086/301711.
69. Sullivan, S. D., Welt, C., and Sherman, S. (2011). FMR1 and the continuum of primary ovarian insufficiency. Semin. Reprod. Med. 29, 299-307. doi: 10.1055/s-0031-1280915.
70. Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., et al. (1992). DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1, 397-400.
71. Tabolacci, E., Moscato, U., Zalfa, F., Bagni, C., Chiurazzi, P., and Neri, G. (2008). Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur. J. Hum. Genet. 16, 1487-1498. doi: 10.1038/ejhg.2008.130.
72. Tassone, F., Beilina, A., Carosi, C., Albertosi, S., Bagni, C., Li, L., et al. (2007). Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 13, 555-562. doi: 10.1261/rna.280807.
73. Tassone, F., Hagerman, R. J., Loesch, D. Z., Lachiewicz, A., Taylor, A. K., and Hagerman, P. J. (2000a). Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet. 94, 232-236. doi: 10.1002/1096-8628(20000918)94:3<232::AID-AJMG9>3.0.CO;2-H.
74. Tassone, F., Hagerman, R. J., Taylor, A. K., Gane, L. W., Godfrey, T. E., and Hagerman, P. J. (2000b). Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6-15. doi: 10.1086/302720.
75. Thomson, J. P., Skene, P. J., Selfridge, J., Clouaire, T., Guy, J., Webb, S., et al. (2010). CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 464, 1082-1086. doi: 10.1038/nature08924.
76. Todd, P. K., Oh, S. Y., Krans, A., Pandey, U. B., Di Prospero, N. A., Min, K. T., et al. (2010). Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome. PLoS Genet. 6:e1001240. doi: 10.1371/journal.pgen.1001240.
77. Tsai, M. C., Manor, O., Wan, Y., Mosammaparast, N., Wang, J. K., Lan, F., et al. (2010). Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689-693. doi: 10.1126/science.1192002.
78. Usdin, K., House, N. C., and Freudenreich, C. H. (2015). Repeat instability during DNA repair: insights from model systems. Crit. Rev. Biochem. Mol. Biol. 50, 142-167. doi: 10.3109/10409238.2014.999192.
79. Usdin, K., and Woodford, K. J. (1995). CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in vitro. Nucleic Acids Res. 23, 4202-4209.
80. Verkerk, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905-914.
81. Wahba, L., and Koshland, D. (2013). The Rs of biology: R-loops and the regulation of regulators. Mol. Cell 50, 611-612. doi: 10.1016/j.molcel.2013.05.024.
82. Wang, Y. H., Gellibolian, R., Shimizu, M., Wells, R. D., and Griffith, J. (1996). Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. J. Mol. Biol. 263, 511-516. doi: 10.1006/jmbi.1996.0593.
83. Weiler, I. J., and Greenough, W. T. (1999). Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. Am. J. Med. Genet. 83, 248-252.
84. Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., et al. (1997). Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U.S.A. 94, 5395-5400.
85. Xi, Z., Zinman, L., Moreno, D., Schymick, J., Liang, Y., Sato, C., et al. (2013). Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 92, 981-989. doi: 10.1016/j.ajhg.2013.04.017.
86. Yap, K. L., Li, S., Munoz-Cabello, A. M., Raguz, S., Zeng, L., Mujtaba, S., et al. (2010). Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662-674. doi: 10.1016/j.molcel.2010.03.021.
87. Yuan, W., Xu, M., Huang, C., Liu, N., Chen, S., and Zhu, B. (2011). H3K36 methylation antagonizes PRC2 mediated H3K27 methylation. J. Biol. Chem. 286, 7983-7989. doi: 10.1074/jbc.M110.194027.
88. Zaitsev, E. N., and Kowalczykowski, S. C. (2000). A novel pairing process promoted by Escherichia coli RecA protein: inverse DNA and RNA strand exchange. Genes Dev. 14, 740-749.
89. Zhao, J., Ohsumi, T. K., Kung, J. T., Ogawa, Y., Grau, D. J., Sarma, K., et al. (2010). Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell 40, 939-953. doi: 10.1016/j.molcel.2010.12.011.
90. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008). Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756. doi: 10.1126/science.1163045.
91. Zumwalt, M., Ludwig, A., Hagerman, P. J., and Dieckmann, T. (2007). Secondary structure and dynamics of the r(CGG) repeat in the mRNA of the fragile X mental retardation 1 (FMR1) gene. RNA Biol. 4, 93-100. doi: 10.4161/rna.4.2.5039.